Skip to main content

BARCLAYS PLC

Position in ARGX — Argenx SE

CIK 312069 LONDON, X0

Position in ARGX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$124,717,337
+$120,700,963 QoQ
Shares Held
134,427
+2344.1% QoQ
Ownership
0.216%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#34
of 496 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARGX Over Time

Shares Held

Position Value (USD)

Derivatives in ARGX

reported options exposure · as of Sep 30, 2024
CallValue
$8,619,072
CallShares
15,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,140,734 across 455 Biotechnology names. ARGX ranks #4 (7.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 ARGX
Argenx SE
This page
134,427 $124,717,337

All Filings in ARGX

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $124,717,337 134,427
2026-03-31 $4,016,374 5,500
2025-12-31 $8,850,998 10,525
2025-09-30 $197,665 268
2025-06-30 $1,370,332 2,486
2025-03-31 $1,510,439 2,552
2024-12-31 $1,268,130 2,062
2024-09-30 $8,619,072 15,900
2024-09-30 $165,333 305
2024-06-30 $11,611,080 27,000
2024-03-31 $11,516,310 29,250
2023-12-31 $1,978,236 5,200
2023-12-31 $15,761,214 41,430
2023-12-31 $7,608,600 20,000
2023-09-30 $19,149,971 38,952
2023-06-30 $2,866,853 7,356
2023-03-31 $14,665,865 39,363
2022-12-31 $36,746 97
2022-09-30 $34,245 97
2022-06-30 $258,774 683
2022-03-31 $30,585 97
2021-12-31 $33,968 97
2021-09-30 $1,470,740 4,870
2021-06-30 $1,268,106 4,212
2021-03-31 $1,283,592 4,661
2020-12-31 $3,323,217 11,300
2020-09-30 $13,126 50
2020-03-31 $13,173 100